Investment firms Tiger Global and Insight Partners led a $100m Series D funding round in Viz.ai, an AI-powered disease detection and care coordination platform, with participation from Scale Ventures, Kleiner Perkins, Threshold, GV, Sozo Ventures, CRV, and Susa. “Viz.ai is committed to helping patients get better, faster and more equitable access to life saving treatments. We will continue to invest heavily in cutting-edge technology and services to integrate deeply into the clinical workflow, allowing us to automate disease detection, increase diagnostic rates, and enhance workflows across the entire hub and spoke health system. More patients receive the right treatment, resulting in better patient outcomes and improved financial efficiency for the health system," Chris Mansi, Viz.ai Co-Founder and CEO.